Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (unaudited)

v3.23.3
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Collaboration revenue $ 0 $ 3 $ 0 $ 66
Operating expenses:        
Research and development 182 170 546 508
Selling, general and administrative 30 33 91 98
Goodwill impairment 0 0 0 1,000
Total operating expenses 212 203 637 1,606
Loss from operations (212) (200) (637) (1,540)
Other income (expense):        
Change in fair value of derivative liabilities 5 (3) (7) 103
Other income, net 17 5 40 8
Loss before income taxes (190) (198) (604) (1,429)
Income tax expense 0 0 0 0
Net loss $ (190) $ (198) $ (604) $ (1,429)
Basic net loss per share (in usd per share) $ (0.13) $ (0.17) $ (0.48) $ (1.26)
Diluted net loss per share (in usd per share) $ (0.13) $ (0.17) $ (0.48) $ (1.26)
Basic weighted-average shares outstanding (in shares) 1,432 1,152 1,261 1,137
Diluted weighted-average shares outstanding (in shares) 1,432 1,152 1,261 1,137